Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES (RENASICA_III)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02141750
Recruitment Status : Completed
First Posted : May 19, 2014
Last Update Posted : May 19, 2014
Sponsor:
Information provided by (Responsible Party):
Third National Registry of Acute Coronary Syndromes

Brief Summary:
The Registry pretends to identify stratification, diagnosis and treatment approaches in patients with Acute Coronary Syndrome (ACS) in community hospitals with tertiary hospitals to optimize resources and identify strategies to improve health care quality through the creation of clinical guidelines that serve for unify management and treatment methods with adherence to international guidelines which include suggestions for treatment and medication.

Condition or disease
Acute Coronary Syndromes

Layout table for study information
Study Type : Observational
Actual Enrollment : 8296 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES
Study Start Date : November 2012
Actual Primary Completion Date : July 2013
Actual Study Completion Date : November 2013



Primary Outcome Measures :
  1. Number of patients with complications after presenting ACS [ Time Frame: up to one year ]
    The main objective will be to know the evolution of ACS in third and second level hospitals with a monitoring at a minimum of one year for each patient.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
It will include patients older than 18 years with ACS final diagnosis and objective evidence of atherosclerotic coronary disease. Patients will be identified in the emergency department, coronary care units, intensive care units, hospital and hemodynamic laboratories
Criteria

Inclusion Criteria:

all patients with suspected ACS and will analyze risk factors, chest pain and electrocardiographic characteristics.

Exclusion Criteria:

Patients with secondary ischemia (anaemia, pulmonary thromboembolism, myocarditis) and type II infarction.


Layout table for additonal information
Responsible Party: Third National Registry of Acute Coronary Syndromes
ClinicalTrials.gov Identifier: NCT02141750    
Other Study ID Numbers: RENASICA III
First Posted: May 19, 2014    Key Record Dates
Last Update Posted: May 19, 2014
Last Verified: May 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Coronary Syndrome
Syndrome
Disease
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases